Baker’s Yeast: Industrial Applications And Health Benefits
DOI:
https://doi.org/10.48165/Keywords:
Anticancer, bioremediation, health supplement, probiotic, yeastAbstract
Baker’s yeast is used as a leavening agent in bread baking as it converts simple fermentable sugars in dough to CO2 and ethanol. Fermentation by yeast leads to the expansion of dough, its maturation and development of characteristic flavours in cereal-based products. Different strains of yeasts like Saccharomyces cerevisiae, S. exiguous, S. boulardii, etc. are widely used in nourishment and pharmaceutical industry. Yeast is a source of vitamin B, minerals, β-glucan fiber and protein and is used as health supplement. As probiotic, it plays a vital role in folate biofortification, detoxification and bioavailability of nutrients. Anti-cholesterolemic, anti-mutagenic, anti-oxidative and anti-tumuor potential of S. cerevisiae is currently under investigation. Yeast is exploited in several industrial processes including bioethanol production and bioremediation and is an excellent tool for biotechnological applications. This paper reviews the work done on baker’s yeast and its industrial application and health benefits.
Downloads
References
Abbas, B.A. and Badr, S.Q. 2015. Bioremediation of some types of heavy metals by Candida spp. International Journal of Engineering and Technical Research, 3: 2454-4698. Aguilar-Uscanga, B. and Francois, J.M. 2003. A study of the yeast cell wall composition and structure in response to growth conditions and mode of cultivation. Letters in Applied Microbiology, 37: 268-274.
Ahluwalia, S.S. and Goyal, D. 2007. Microbial and plant derived biomass for removal of heavy metals from wastewater. Bioresource Technology, 98: 2243-2257.
Al-Farsi, M., Alasalvar, C., Al-Abid, M., Al-Shoaily, K., Al-Amry, M. and Al-Rawahy, F. 2007. Compositional and functional characteristics of dates, syrups and their by-products. Food Chemistry,104: 943-947.
Anushree M. 2004. Metal bioremediation through growing cells. Environment International, 30: 261- 278.
Assis Fidalgo, C.I. 2011. Heavy Metal Resistance in Extremophilic Yeasts: A Molecular and Physiological Approach. M.Sc. thesis, Department of Plant Biology, Science College, University of Lisbon, Lisbon, Portugal.
Badr El-Din, N.K., Mahmoud, A.Z., Hassan, T.A. and Ghoneum, M. 2017. Baker’s yeast sensitizes metastatic breast cancer cells to paclitaxel in vitro. Integrative Cancer Therapies, 17: 542-550.
Jaspreet Kaur and Priya Katyal
Bahafid, W., Joute, N.T., Asri, M., Sayel, H., Tirry, N., Joutey, N.E.T., Asri, M., Sayel, M., Tirry, N. and Naïma El Ghachtouli. 2007. Yeast biomass: An alternative for bioremediation of heavy metals. pp. 269-289. In: Yeast - Industrial Applications. INTECH Open Access Publisher, London, UK.
Basso, L.C., Henrique, V., de Amorim., Antonio, J., de Oliveira., Mario, L. and Lopes. 2008. Yeast selection for fuel ethanol production in Brazil. FEMS Yeast Research, 8: 1155-1163. Bekatorou, A., Psarianos, C. and Koutinas, A. 2006. Food grade yeasts. Food Technology and Biotechnology, 44: 407-415.
Chen, L.S., Ma, Y., Maubois, J.L., He, S.H., Chen, L.J. and Li, H.M. 2010. Screening for the potential probiotic yeast strains from raw milk to assimilate cholesterol. Dairy Science Technology, 90: 537-548.
Cindoruk, M., Erkan, G., Karakan, T., Dursun, A. and Unal, S. 2007. Efficacy and safety of Saccharomyces boulardii in the14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study. Helicobacter, 12: 309-316.
Coté, G.A. and Buchman, A.L. 2006. Antibiotic-associated diarrhoea. Expert Opinion on Drug Safety, 5: 361-372.
Czerucka, D., Piche, T. and Rampal, P. 2007. Review article: Yeast as probiotics – Saccharomyces boulardii. Alimentary Pharmacology and Therapeutics, 26: 767-778.
Erdeve, O.; Tiras, U. and Dallar, Y. 2004. The probiotic effect of Saccharomyces boulardii in a pediatric age group. Journal of Tropical Pediatrics, 50: 234-238.
Etienne-Mesmin, L., Livrelli, V., Privat, M., Denis, S., Cardot, J.M., Alric, M. 2011. Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Applied and Environmental Microbiology, 77: 1127-1131.
FAO. 2002. Guidelines for the Evaluation of Probiotics in Food. Food and Agriculture Organization of the United Nations, London/Ontario, Canada.
Ghoneum, M. and Gollapudi, S. 2004. Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker’s yeast, in vitro. Anticancer Research, 24: 1-29.
Ghoneum, M., Wang, L., Agrawal, S., Gollapudi, S. 2007. Yeast therapy for the treatment of breast cancer: A nude mice model study. In vivo, 21: 251-258.
Goldemberg, J. 2007. Ethanol for a sustainable energy future. Science, 315(5813): 808-810. Gómez-Pastor, R., Pérez-Torrado, R., Garre, E. and Matallana, E. 2011. Recent advances in yeast biomass production. pp. 201-222. In: Detection, Production and Usage (ed. D. Matovic). INTECH Open Access Publisher, London, UK.
Hatoum, R., Labrie, S. and Fliss, I. 2012. Identification and partial characterization of antilisterial compounds produced by dairy yeasts. Probiotics and Antimicrobial Proteins, 3:1-10. Hjortmo, S.B., Hellstrom, A.M. and Andlid, T.A. 2008 Production of folates by yeasts in Tanzanian fermented togwa. FEMS Yeast Research, 8: 781-787.
Hoekman, S.K. 2009. Biofuels in the U.S. – Challenges and opportunities. Renewable Energy, 34: 14-22.
Hosseinzadeh, P., Djazayery, A., Mostafavi, S.A., Javanbakht, M.H., Derakhshanian, H., Rahimiforoushani, A., and Djalali, M., 2013 Brewer’s yeast improves blood pressure in type 2 diabetes mellitus. Iranian Journal of Public Health, 42: 602-609.
Ikeda, Y., Adachi, Y., Ishii, T., Miura, N., Tamura, H. and Ohno, N. 2008. Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity. Biological and Pharmaceutical Bulletin, 31: 13-18.
Jach, M.E., Serefko, A., Sajnaga, E., Kozak, E., Poleszak, E. and Malm, A. 2015. Dietary supple ments based on the yeast biomass. Current Topics in Nutraceutical Research, 13: 83-88. Johnson, E.A. and Echavarri-Erasun, C. 2011. Yeast biotechnology. pp. 21-44. In: The Yeasts, A
Taxonomic Study (5th edn) (eds. C. Kurtzman, J.W. Fell and T. Boekhout). Elsevier Science, Amsterdam, Netherland.
Baker’s yeast: Industrial applications and health benefits 113
Kelesidis, T. and Pothoulakis, C. 2011. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology, 5(2): 111-125.
Kumura, H., Tanoue, Y., Tsukahara, M., Tanaka, T. and Shimazaki, K. 2004. Screening of dairy yeast strains for probiotic applications. Journal of Dairy Science, 87: 4050-4056.
Lallemand Baking Update. 2011. Yeast Characteristics. Practical Technology. Lallemand Inc., Montréal, Canada
McFarlin, B.K., Henning, A.L., Bowman, E.M., Gary, M.A. and Carbajal, K.M. 2017. Oral spore based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides and disease risk biomarkers. World Journal of Gastrointestinal Pathophysiology, 8(3): 117-126.
Moyad, M.A. 2008. Brewer’s/Baker’s yeast (Saccharomyces cerevisiae) and preventive medicine: Part II. Urologic Nursing, 28: 73-75.
Moslehi-Jenabian, S., Lindegaard, L., Pedersen and Jespersen, L. 2010. Beneficial effects of probiotic and food-borne yeasts on human health. Nutrients, 2: 449-473.
Nancharaiah, Y.V., Mohan, S.V. and Lens, P.N.L. 2016. Biological and bioelectrochemical recovery of critical and scarce metals. Trends in Biotechnology, 34: 137-155.
Newberry, S.J. 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea. The Journal of American Medical Association, 307: 1959-1969.
Olstorpe, M., Schnurer, J. and Passoth, V. 2009. Screening of yeast strains for phytase activity. FEMS Yeast Research, 9: 478-488.
Perera, F. 2017. Pollution from fossil-fuel combustion is the leading environmental threat to global pediatric health and equity: Solutions exist. International Journal of Environmental Research and Public Health, 15: 15-16.
Psani, M. and Kotzekidou, P. 2006. Technological characteristics of yeast strains and their potential as starter adjuncts in Greek style black olive fermentation. World Journal of Microbiology and Biotechnology, 22: 1329-1336.
Rajkowska, K., Kunicka-Styczynska, A. and Rygala, A. 2012. Probiotic activity of Saccharomyces cerevisiae var. boulardii against human pathogens. Food Technology and Biotechnology, 50: 230-236.
Richard, C. 2006. Brazil: A world leader. Sugar Journal, 69: 11-15.
Selinger, C.P., Bell, A., Cairns, A., Lockett, M., Sebastian, S. and Haslam, N. 2013. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. Journal of Hospital Infection, 84: 159-165.
Van der Walt, J.P. 1970. Kluyveromyces van der Walt emend van der Walt. Pp. 1059-67. In: The Yeasts: A Taxonomic Study (2nd edn) (ed. J. Lodder). North Holland Publishing Co., Amsterdam, Netherlands.
Vilela, E.G., Ferrari, M.D.D., Torres, H.O.D., Pinto, A.G., Aguirre, A.C.C., Martins, F.P., Goulart, E.M.A. and Da Cunha, A.S. 2008. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scandinavian Journal of Gastroenterology, 43: 842-848.
Volesky B. 1994. Advances in biosorption of metals: Selection of biomass types. FEMS Microbiology Review, 14: 291-302.
Whelan, K. 2007. Enteral-tube-feeding diarrhoea: Manipulating the colonic microbiota with probiotics and prebiotics. Proceedings of Nutrition Society, 66: 299-306.
Wu, Q., Jezkova, A., Yuan, Z., Pavlikova, L., Dohnal, V. and Kuca, K. 2009. Biological degradation of aflatoxins. Drug Metabolism Reviews, 41: 1-7.
Downloads
Published
Issue
Section
How to Cite
